Evidence map›Paper›PMID 34629849›Full record

ArticleEnfermeria clinica2021

[Recommendations for use of the diverse tests for detection of SARS-COV-2 infection].

Lidia Gestoso-Pecellín, Yuneysa García-Flores, Pino González-Quintana, José Luis Marrero-Arencibia

Open access · greenAbstract read
In one paragraph

Article in Enfermeria clinica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. [Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-2].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lidia Gestoso-PecellínSOS Madrid, Madrid, España.
Yuneysa García-FloresGerencia de Atención Primaria de Gran Canaria, Gran Canaria, España.
Pino González-QuintanaGrupo de intervención a domicilio, Gerencia de Atención Primaria de Gran Canaria, Gran Canaria, España.
José Luis Marrero-ArencibiaÁrea técnica de suministros, Gerencia Atención Primaria de Gran Canaria, Gran Canaria, España.
Gobierno de Canarias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current crisis caused by SARS-CoV-2, there is a global need to know and combat the virus. One of the strategies is to track and diagnose cases in order to isolate and interrupt the epidemiological chain. Therefore, the aim of this article is to describe the different most used diagnostic tests and analyze their validity and indications for use according to scientific evidence and the main recommendations of scientific societies and reference organizations at national and international level. Since the beginning of the pandemic, the availability of tests has been subject to the conditions of the manufacturing market itself and to the guidelines set in each country. Among the most used types of tests, it is worth highlighting PCR, antibody detection tests (IgG and IGM) and total antibodies (Ab), also known as rapid tests, and tests for the detection of antigens in nasopharyngeal exudate or other upper/lower respiratory samples. For each of these tests, it is necessary to know their recommendations for use and the procedure for taking samples, which is essential to minimize alterations in the results due to poor handling. Likewise, it is necessary to determine the most appropriate moment for taking samples and their adequate interpretation of the results obtained, which must always be considered together with the patient's symptoms for clinical decision-making.

Indexed as

COVID-19SARS-CoV-2HumansPandemicsCoronavirus infectionsCOVID-19DiagnosisSARS-CoV-2SARS virusTest

Identifiers

PMID34629849
PMCPMC7556773
OpenAlexW3100599848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.